AIBIOS
Irvine
About AIBIOS
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.9M
- Funding stage: Seed
- Last round: Seed (Apr 2021)
- Website: aibios.com
- Phone: +1 949-812-8023
Industries & Categories
Bioinformatics, Biotechnology, Product Research
Canonical: https://fsome.com/organization/aibios-28741 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.